Ixeris polycephala Extract Alleviates Progression of Benign Prostatic Hyperplasia via Modification of Proliferation, Apoptosis, and Inflammation
Pharmaceuticals · 05.08.2024 · 17 (8) · 1032
DOI: 10.3390/ph17081032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 05.08.2024. Verfasst von Eun-Bok Baek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chungnam National University, re, Food and Rural Affairs (MAFRA), Ministry of Agriculture, Food, and Rural Affairs (MAFRA).
Abstract (Originalsprache)
Benign prostatic hyperplasia (BPH) is a urogenital disorder that is common in aging men. Ixeris polycephala (IP) is used in traditional medicine and contains pharmacologically active compounds. However, the effect for BPH progression has not been elucidated. We herein examined the protective potential of IP extract on a testosterone-induced model of BPH in rats. To generate the BPH model, daily subcutaneous administration of testosterone was applied for 4 weeks. During this period, the rats were also administered a daily oral gavage of IP (150 mg/kg), finasteride (positive control), or vehicle. Testosterone treatment was associated with a significantly higher prostate-to-body weight ratio, serum dihydrotestosterone (DHT) level, and prostatic gene expression of 5α-reductase compared to untreated controls. Notably, IP plus testosterone co-treatment was associated with decreased epithelial thickness, down-regulation of proliferating cell nuclear antigen (PCNA) and cyclin D1, and upregulation of pro-apoptotic signaling molecules. IP co-treatment also down-regulated pro-inflammatory cytokines, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) and decreased inflammatory cell infiltration compared to the levels seen in the testosterone-induced BPH. IP appears to protect rats against the progression of testosterone-induced BPH by alleviating prostate cell growth and inflammatory responses, and thus may have potential for clinical use against BPH progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.
- Herbal Medicine Research Division, Korean Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
- Laboratory Animal Resource Center, Korean Research Institute of Bioscience and Biotechnology, Chungbuk 34141, Republic of Korea.
ORCID-Profile: Eun-Bok Baek, Youn-Hwan Hwang
Förderung
- Chungnam National University
- re, Food and Rural Affairs (MAFRA)
- Ministry of Agriculture, Food, and Rural Affairs (MAFRA)
Zitieren
APA
Baek, E. B., Hwang, Y. H., Hong, E. J., Won, Y. S., & Kwun, H. J. (2024). Ixeris polycephala Extract Alleviates Progression of Benign Prostatic Hyperplasia via Modification of Proliferation, Apoptosis, and Inflammation. Pharmaceuticals, 17(8), 1032. https://doi.org/10.3390/ph17081032
Vancouver
Baek EB, Hwang YH, Hong EJ, Won YS, Kwun HJ. Ixeris polycephala Extract Alleviates Progression of Benign Prostatic Hyperplasia via Modification of Proliferation, Apoptosis, and Inflammation. Pharmaceuticals. 2024;17(8):1032. doi:10.3390/ph17081032
BibTeX
@article{Baek2024,
author = {Baek, Eun-Bok and Hwang, Youn-Hwan and Hong, Eun-Ju and Won, Young-Suk and Kwun, Hyo-Jung},
title = {Ixeris polycephala Extract Alleviates Progression of Benign Prostatic Hyperplasia via Modification of Proliferation, Apoptosis, and Inflammation},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {8},
pages = {1032},
doi = {10.3390/ph17081032}
}
EUVIMED